AZ/MedImmune's FluMist gets big boost with new indication

Matthew Arnold

September 19 2007

MedImmune announced that the FDA has approved the use of its FluMist in children 2-5 years old, an indication that ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.